As of December 1, 2020, Nurse Practitioners in Saskatchewan will no longer be required to complete 600 clinical hours to maintain eligibility for registration. According to CRNS Bylaw VI subsection 3(7), NPs are required to work in nurse practitioner activities approved by the association in one of the four specialties for at least 900 hundred hours in the three years immediately preceding application. However, there is no longer a requirement for clinical hours.
This modification was made in recognition of changes in NP practice acknowledging the increasing diversity with many NPs working in various domains of practice outside of a clinical setting.
For any questions regarding this change, please email Leah White, RN Nursing Advisor (email@example.com)
In response to an updated Health Canada advisory warning that patients under 18 years of age should not use non-prescription pain relief products containing codeine, the Prescription Review Program (PRP), Saskatchewan’s prescription monitoring program, has released correspondence to assist practitioners with the management of pediatric pain and provide guidance in regards to the use of codeine products.
The update by Health Canada also included warnings regarding the use of prescription cough and cold products containing opioids in patients under 18 years of age. Research has suggested that early exposure to opioids may put young patients at risk for opioid-related adverse events throughout their life.
Given it’s perceived safety, codeine was previously a preferred opioid drug in pediatrics, it has since been recommended that practitioners do not initiate treatment with codeine if the patient hasn’t been prescribed the drug for a chronic condition in the past.
Correspondence shared by the Prescription Review Program, elaborates on the above topics further, outlines non-opioid and non-pharmacological options in pediatric pain management and highlights important reminders if an opioid prescription is deemed necessary in a pediatric patient.
Review this document here.
If you have any questions, please contact Susan Furman-Pelzer, NP Nursing Advisor PRP (firstname.lastname@example.org).
Nurse Practitioners (NP) in Saskatchewan can prescribe bioactive agents and medical fillers for cosmetic purposes when:
- the patient condition for which they are prescribing the agents fall within the individual NP common medical disorders and
- the NP has the knowledge, skills and competence to safely assess, treat, prescribe and/or administer the product in accordance with bylaws, standards and competencies and federal legislation.
NPs work within a collaborative team of physicians, registered nurses (RN) and other health care providers to implement the nursing process including assessment, care planning, implementation and evaluation. Considerations for NPs when practicing in an interdisciplinary setting:
- Recognition of practice is required for NPs who practice in the most responsible practitioner role. Contact email@example.com for further information.
- The most responsible practitioner is responsible to:
- conduct an initial assessment of the client at each visit;
- establish a treatment plan for the injection;
- assess that the RN providing the injection is competent to perform the task; and,
- be available to provide assistance in the event of an untoward event.
- RN Clinical Protocols are required to provide guidance to RNs who are administering these products under the authority of NPs. The four essential components for RN Specialty Practices must be incorporated into the RN Clinical Protocol.
Providing cosmetic services and procedures has evolved over the past several years and includes unique liability risks that NPs should understand prior to engaging in this area of practice. It is strongly recommended that NPs contact the Canadian Nurses Protective Society (CNPS) to discuss liability risks associated with cosmetic nursing.
Questions? Contact an CRNS Practice Advisor by phone: 1-800-667-9945 or 306-359-4227 or by email: firstname.lastname@example.org.